<DOC>
	<DOCNO>NCT00829231</DOCNO>
	<brief_summary>This study find subject 's body process reacts study drug , find long remain subject system one dose . Subjects vary degree liver function ask participate study . Study result subject normal liver function compare study result subject impaired liver function .</brief_summary>
	<brief_title>Hepatic Impairment Study</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Healthy Subjects , Child Pugh A Child Pugh B Liver Disease Patients .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Liver disease</keyword>
</DOC>